Screening and Prevention News for October 23, 2024
advertisement
- TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trial
- A novel class of oral, non-immunosuppressive, beta cell-targeting, TXNIP-inhibiting T1D drugs is emerging
- A regulatory variant rs9379874 in T1D risk region 6p22.2 affects BTN3A1 expression regulating T cell function
- Decoding the relationship between cow’s milk proteins and development of type 1 diabetes mellitus
- Gut microbial metabolic signatures in diabetes mellitus and potential preventive and therapeutic applications
- Therapy concepts in type 1 diabetes mellitus treatment: disease modifying versus curative approaches
- Type I Diabetes Mellitus impairs cytotoxic immunity through CEACAM5 upregulation in colorectal cancer : Exploring the intersection of autoimmune dysfunction and cancer progression: the role of NF-κB p65 in colorectal cancer
- Vemurafenib inhibits the replication of diabetogenic enteroviruses in intestinal epithelial and pancreatic beta cells
